Paid Clinical Trials Knoxville
Discover 187 paid clinical trials in Knoxville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Observational StudyPancreatic Cancer Early Detection Consortium
Sponsor:
Arbor Research Collaborative for Health
Location:
Code:
NCT04970056
Conditions
Pancreas Cancer
Pancreas Cyst
Pancreatic Ductal Adenocarcinoma
Genetic Predisposition
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
OfatumumabPharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT06869785
Conditions
Relapsing Multiple Sclerosis (RMS)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ofatumumab approved dose
Ofatumumab new dose
AcyclovirPhase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
Sponsor:
National Center for Research Resources (NCRR)
Location:
Code:
NCT00006132
Conditions
Herpes Simplex
Eligibility Criteria
Sex: All
Age: 0 - 28
Healthy Volunteers: Not accepted
Interventions
acyclovir
Fianlimab & CemiplimabA Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT05800015
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
fianlimab
cemiplimab
Pemetrexed
Paclitaxel
Carboplatin
DB-1303/BNT323 vs. ChemotherapyA Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
Sponsor:
DualityBio Inc.
Location:
Code:
NCT06018337
Conditions
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
DB-1303/BNT323
Capecitabine
Paclitaxel
Nab-paclitaxel
Interested in new trials?
Get alerts for new trials in your area by subscribing now
BirtamimabA Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients with AL Amyloidosis
Sponsor:
Prothena Biosciences Ltd.
Location:
Code:
NCT04973137
Conditions
Light Chain (AL) Amyloidosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Birtamimab
Placebo
Standard of Care Chemotherapy
Observational StudyNeuroinflammation and Alzheimer's Pathology in POCD
Sponsor:
University of Tennessee Graduate School of Medicine
Location:
Code:
NCT05378659
Conditions
Post-Operative Confusion
Neuroinflammatory Response
Alzheimer Disease
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Accepted
Interventions
Montreal Cognitive Assessment
Stroop Test
4AT Delirium
Grooved Pegboard
NACC Cognitive Battery
Pembrolizumab & Sacituzumab TirxumotecanA Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06312137
Conditions
Non Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab tirumotecan
Pembrolizumab
Cisplatin
Pemetrexed
Gemcitabine
HAV vs. AVFTo Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
Sponsor:
Humacyte, Inc.
Location:
Code:
NCT05908084
Conditions
End Stage Renal Disease (ESRD)
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Acellular Tissue Engineered Vessel (ATEV)
AVF
BION-1301A Study of Zigakibart in Adults With IgA Nephropathy
Sponsor:
Chinook Therapeutics, Inc.
Location:
Code:
NCT05852938
Conditions
IgA Nephropathy
Immunoglobulin A Nephropathy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BION-1301
Placebo